CUHK Medical Centre

You only have one 🧠 - take good care of it! There is a lot you can do for a healthy brain: 🏃♂️ Keep physically active 🍌 Eat a healthy diet 😴 Get enough sleep 🧩 Stimulate your mind 💟 Look after your heart ⛑️ Wear a helmet #BrainHealth

【Dare to Dream – My Journey from Art, Medicine to Robotics and Translational Research】“With the current robotic surgical system, the laparoscope serves as our eyes and the robotic arm as an extension of our hands, while surgeons still serve as the brain, orchestrating the surgical procedure. We believe that in the future, artificial intelligence will serve as our co-pilot in mastering complex robotic surgical procedures.” Professor Philip Chiu, Dean of CU Medicine, has been named Shun Hing Education and Charity Fund Professor of Robotic Surgery for his pioneering spirit and dedication in promoting novel endoscopic technologies and robotics for the management of early upper gastrointestinal (GI) cancers through translational research, in Hong Kong and beyond. In the role’s inaugural lecture, Professor Chiu, a world-renowned surgeon in upper GI surgery and novel endoscopic and robotic surgery, shared his life journey, from the training and inspiration he received from Chinese art to his mastery of surgery, robotics and translational research. Professor Philip Chiu’s upbringing fostered his interest in both medicine and Lingnan art from a young age. With a passion to help as many people as possible, he chose to become a doctor. He obtained his Bachelor of Medicine and Bachelor of Surgery degree in 1994 and his Doctor of Medicine degree in 2009, both from CUHK. The practice of Chinese art empowers him to excel in the field of surgery. He has said that the precise hand-eye coordination and meticulous planning required in painting are similar to those required when performing surgery. Recognising that the prognosis of patient with upper GI cancer depends not on the perfection of surgery or oncological therapy but on the stage of diagnosis, Professor Chiu went to study in Japan in 2003 under Professor Haruhiro Inoue, to learn the endoscopic diagnosis and treatment of early upper GI cancers, a novel, minimally invasive approach. The next year, he became the first in Hong Kong to perform endoscopic submucosal dissection (ESD) to treat early GI cancers. This groundbreaking procedure preserved the patient’s organ, which would have otherwise required conventional removal surgery. Inspired by one of his favourite science fiction series, Star Trek, Professor Chiu’s childhood dream was to “boldly go where no one has gone before”. It has since become more than a dream for him, as he has achieved many firsts in the exploration of diagnostic and treatment options for early GI patients over the years. His work has also been recognised with numerous prestigious awards. Details: https://bit.ly/3Wm2zQZ #CUMedicine #ProfPhilipChiu #ShunHingEducationandCharityFund #Professorship #RoboticSurgery

#Tuberculosis - or TB - is caused by bacteria Mycobacterium tuberculosis that mainly affects the lungs. Common symptoms include ❗️ Cough ❗️ Chest pains ❗️ Weight loss ❗️ Fever ❗️ Night sweats Learn more about TB 👉bit.ly/3Vo428E #EndTB

🌟 Step into CUHKMC's smart hospital journey driven by 5G, IoT, and automation! Dr. Hong Fung, CEO of CUHK Medical Centre, shares how smart technologies have elevated patient care and value. Get inspired by their success story and explore similar topics at Hospital Management Asia 2024 in Bali this August! 🏥💡 Read more: https://bit.ly/3TejtgZ #HealthcareInnovation #SmartHospital #HMA2024

【World EyeCon 21🌏】The Asia-Pacific Journal of Ophthalmology (APJO) established the “World EyeCon21” to recognise the most influential and exemplary ophthalmologists and visual scientists in the world of the 21st century. This year, a total of 24 world ophthalmology leaders were honoured, including Professor Clement CY THAM, Chairman of the Department of Ophthalmology and Visual Sciences at CU Medicine. Prof Tham is one of the only two awardees from Hong Kong. The "World EyeCon21" is organised by the renowned international medical journal Asia-Pacific Journal of Ophthalmology (APJO) biannually. Each awardee has achieved excellence in their respective subspecialties, promoted advancement and innovation in ophthalmology, and made significant contributions to global eye health. The list also includes deceased notable figures in the field of ophthalmology, as a tribute to their enduring impact and contribution, such as Charles Kelman, Charles Schepens, and Arthur Lim. The Award Ceremony was held at the Asia-Pacific Academy of Ophthalmology (APAO) annual congress in Bali, Indonesia, on 22 February 2024. Prof Tham is a renowned clinician-scientist, with research interests in Glaucoma. Prof Tham is also a key leader in international ophthalmology. He has been the Secretary General and CEO of the Asia-Pacific Academy of Ophthalmology (APAO) for the past 11 years, and currently the President Elect of the Asia-Pacific Glaucoma Society. Prof Tham is the immediate past Treasurer of the International Council of Ophthalmology (ICO), the largest ophthalmic professional society in the world with more than 180 national, regional, and subspecialty Member Societies from around the world. Prof Tham was Chair of the Scientific Program Committees of the World Ophthalmology Congress (WOC) 2016 in Mexico, and WOC2018 in Spain. More than 2000 distinguished experts from around the world participated in the scientific programmes in each of these WOCs. Prof Tham is recognised by ExpertScape, an international index of academic achievement and expertise in healthcare, as the top 1% of research scholars in Glaucoma, and ranked #5 in the “2023 Asia-Pacific 100 Most Influential Ophthalmologists” election. Picture: Prof Clement THAM received the award from Prof Ava HOSSAIN, President of Asia-Pacific Academy of Ophthalmology (left), and Prof Jost JONAS, the Chairman of the Judging Panel (right) at the Award Ceremony. #CUMedicine #WorldEyeCon21 #ProfClementTHAM

【Sweet dreams are within reach with novel OSA treatment😴💝】 Obstructive sleep apnoea (OSA) is a common form of sleep-disordered breathing. Continuous positive airway pressure treatment is effective for patients with OSA, but it has to be used every night and is not curative, resulting in low compliance. Upper airway stimulation (UAS) is an emerging surgical procedure for patients who have problems accepting or adhering to standard continuous positive airway pressure treatment. CU Medicine introduced this surgical innovation to patients in February 2023, making Hong Kong the third location in Asia to do so, after Singapore and Japan. The CU Medicine research team has completed three cases as of now, successfully improving the patients’ condition from severe to mild. All three patients were subsidised by the Alice Ho Miu Ling Nethersole Charity Foundation to receive the treatment. Details: https://bit.ly/3T7JL61 #CUMedicine #SleepApnoea #OSA #UAS

🦽 Wheelchairs 👓 Glasses 🦻 Hearing aids 🦿 Prostheses 📱 Digital devices   #AssistiveTechnology helps people live with greater autonomy by facilitating daily activities they would otherwise be unable to do well or at all.   This includes people with chronic health conditions or physical impairments, temporary injuries & diseases, older people & people with disabilities. Learn more 👉bit.ly/47EZSM2 ATscale, the Global Partnership for Assistive Technology